Advertisement
Research Article

An Analytical Method for Assessing Stage-Specific Drug Activity in Plasmodium vivax Malaria: Implications for Ex Vivo Drug Susceptibility Testing

  • Douglas H. Kerlin,

    Affiliation: Malaria Drug Resistance and Chemotherapy Laboratory, Queensland Institute of Medical Research, Brisbane, Australia

    X
  • Kane Boyce,

    Affiliation: Malaria Drug Resistance and Chemotherapy Laboratory, Queensland Institute of Medical Research, Brisbane, Australia

    X
  • Jutta Marfurt,

    Affiliation: Menzies School of Health Research and Charles Darwin University, Darwin, Australia

    X
  • Julie A. Simpson,

    Affiliation: Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, Australia

    X
  • Enny Kenangalem,

    Affiliations: Papuan Health and Community Development Foundation (PHCDF), Timika, Papua, Indonesia, District Health Authority and the Menzies School of Health Research-National Institute of Health Research and Development, Timika, Papua, Indonesia, District Ministry of Health, Timika, Papua, Indonesia

    X
  • Qin Cheng,

    Affiliation: Department of Drug Resistance and Diagnostics, Australian Army Malaria Institute, Brisbane, Australia

    X
  • Ric N. Price,

    Affiliations: Menzies School of Health Research and Charles Darwin University, Darwin, Australia, Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom

    X
  • Michelle L. Gatton mail

    Michelle.Gatton@qimr.edu.au

    Affiliation: Malaria Drug Resistance and Chemotherapy Laboratory, Queensland Institute of Medical Research, Brisbane, Australia

    X
  • Published: August 07, 2012
  • DOI: 10.1371/journal.pntd.0001772

Reader Comments (0)

Post a new comment on this article